MARKET

CDXC

CDXC

ChromaDex
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.990
+0.160
+4.18%
After Hours: 3.990 0 0.00% 16:47 12/11 EST
OPEN
3.840
PREV CLOSE
3.830
HIGH
3.990
LOW
3.780
VOLUME
207.70K
TURNOVER
--
52 WEEK HIGH
4.950
52 WEEK LOW
2.680
MARKET CAP
236.94M
P/E (TTM)
-7.0732
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CDXC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CDXC News

  • ChromaDex launches Tru Niagen Pro 500
  • seekingalpha.14h ago
  • ChromaDex Launches Tru Niagen® Pro 500, the Largest Serving of Patented Nicotinamide Riboside Available Worldwide
  • GlobeNewswire.19h ago
  • ChromaDex Reports Expansion Of Retail Partnership With Matakana For Australia, New Zealand, No Terms Disclosed
  • Benzinga.6d ago
  • ChromaDex and Matakana Announce Expanded Retail Partnership in Australia & New Zealand
  • GlobeNewswire.6d ago

More

Industry

Biotechnology & Medical Research
-0.34%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About CDXC

Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.
More

Webull offers Chromadex Corp (CDXC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.